A Milestone Moment for Teal Health as Nationwide Clinical Study Kicks Off
- Today, we’re proud to announce that Teal Health’s clinical trial is underway to support the FDA approval of our at-home cervical cancer screening device collecting for hrHPV, the Teal Wand.
- Since launching the study about a month ago, we have had immediate traction and are nearly a quarter of the way through our study.
- Prior to this study, Teal conducted a 225+ person study, where we were able to prove that not only were women able to collect an adequate sample with equivalent results to that of the clinician collected sample, but that it was a much preferred experience.
This is your world, shape it or someone else will.
The quote “This is your world, shape it or someone else will'' has always rang true with what we are doing at Teal Health. We’re on a mission to reshape women’s health starting with cervical cancer screenings. And today, we’re proud to announce that Teal Health’s clinical trial is underway to support the FDA approval of our at-home cervical cancer screening device collecting for hrHPV, the Teal Wand. At Teal, our goal is to ensure that all women and people with a cervix are screened for cervical cancer by giving the option to comfortably, conveniently, and privately self-collect from home.
This is a milestone moment for the company, and we are thrilled to have such exceptional and well respected clinical investigators and study sites, and phenomenal participants who are readily raising their hand to shape the future of cervical cancer screenings for all women and people with a cervix. It is truly a group effort and it has been so energizing to see the excitement for this study. Since launching the study about a month ago, we have had immediate traction and are nearly a quarter of the way through our study. We are so grateful for the passion and motivation across our 16 sites including Johns Hopkins, Yale University, University of Colorado, University of Wisconsin, Washington University, multiple Planned Parenthood locations, Woman’s Hospital in Baton Rouge, Alabama Clinical Therapeutics/Birmingham OBGYN, Unified Women’s Clinical Research, and more still signing up.
This clinical study announcement comes during Cervical Cancer Awareness month, and on the heels of the Biden Women’s Health Initiative, which highlights “women have been understudied and underrepresented in health research for far too long. Research on women’s health is drastically underfunded, leading to significant research gaps, with serious consequences for the health of women across the country.” We’re dedicated to closing this gap, and lucky to have the funding from mission aligned investors who understand the magnitude and importance of what we are doing.
Through this SELF-CERV study, we are paving the way for more women to understand the power they hold to be a part of leading research that affects them and their communities.
Holding the Highest of Standards
Teal Health is looking to make our national cervical cancer screening more accessible by bringing it home. It is absolutely critical that the rigorous standards of the FDA are met in order to keep women healthy and prevent cervical cancer. Teal’s study and the caliber of the institutions working with us are a testament to our commitment to safety and efficacy.
Prior to this study, Teal conducted a 225+ person study, where we were able to prove that not only were women able to collect an adequate sample with equivalent results to that of the clinician collected sample, but that it was a much preferred experience.
- 97% of women said it was easy or very easy to use
- 92% said they would choose self-collect over the current standard of care with a clinician collecting
- 87% said they would be more likely to get screened if the Teal Wand were an option.
This is why we work so hard to do what we do. Women want and deserve a better option, one that gives them control over their own bodies.
Self-collection is a much preferred alternative, and has already been adopted in other countries, including Australia and many European countries. Because they make HPV screening and vaccination options widely available, Australia is on track to eliminate cervical cancer as a public health concern by 2035.
More than just collection.
Teal Health is a complete cervical cancer screening and telehealth solution. As important as it is to screen, understanding those results and taking any required follow-up steps is critical to truly prevent cancer. We will offer women telehealth visits to understand their results as well as general gynecological preventive care. Half of US counties don't have an OBGYN. This shortage means that OBGYNs are overworked, and women aren’t able to access annual wellness and screenings specific to a women’s health journey. Teal is committed to closing the women's health gap.
Too important to wait.
While we look forward to being able to bring the Teal Wand to women and people with a cervix, getting screened is too important to wait. So if you are due for a screening, schedule one today! Join our waitlist and follow us on instagram to be notified when a self-collection option is FDA approved.
Hear more about what we’re building with Kara Egan’s presentation from Emerson Collective’s Dial Fellowship.